CN102872093B - Houttuynoid E在治疗胰腺癌药物中的应用 - Google Patents
Houttuynoid E在治疗胰腺癌药物中的应用 Download PDFInfo
- Publication number
- CN102872093B CN102872093B CN 201210418798 CN201210418798A CN102872093B CN 102872093 B CN102872093 B CN 102872093B CN 201210418798 CN201210418798 CN 201210418798 CN 201210418798 A CN201210418798 A CN 201210418798A CN 102872093 B CN102872093 B CN 102872093B
- Authority
- CN
- China
- Prior art keywords
- houttuynoid
- medicine
- pancreatic cancer
- application
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010061902 Pancreatic neoplasm Diseases 0.000 title claims abstract description 25
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 title claims abstract description 17
- VCNWTZPWIVDHGN-SLBJRTIWSA-N 2-[4,5-dihydroxy-2-(2-oxoundecyl)phenyl]-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound CCCCCCCCCC(=O)CC1=CC(O)=C(O)C=C1C1=C(O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 VCNWTZPWIVDHGN-SLBJRTIWSA-N 0.000 title abstract description 40
- 208000008443 pancreatic carcinoma Diseases 0.000 title abstract description 14
- 201000002528 pancreatic cancer Diseases 0.000 title abstract description 8
- 150000001875 compounds Chemical class 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 13
- 229930190556 houttuynoid Natural products 0.000 claims description 4
- 230000012010 growth Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 230000000259 anti-tumor effect Effects 0.000 abstract description 2
- 238000011161 development Methods 0.000 abstract description 2
- 238000011156 evaluation Methods 0.000 abstract description 2
- 230000002946 anti-pancreatic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 description 6
- 208000009889 Herpes Simplex Diseases 0.000 description 4
- 241000700584 Simplexvirus Species 0.000 description 4
- 230000003602 anti-herpes Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 240000000691 Houttuynia cordata Species 0.000 description 3
- 235000013719 Houttuynia cordata Nutrition 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 229940041181 antineoplastic drug Drugs 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210418798 CN102872093B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid E在治疗胰腺癌药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210418798 CN102872093B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid E在治疗胰腺癌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872093A CN102872093A (zh) | 2013-01-16 |
CN102872093B true CN102872093B (zh) | 2013-08-28 |
Family
ID=47473764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210418798 Expired - Fee Related CN102872093B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid E在治疗胰腺癌药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872093B (zh) |
-
2012
- 2012-10-27 CN CN 201210418798 patent/CN102872093B/zh not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
Houttuynoids A-E,Anti-Herpes Simplex Virus Active Flavonoids with Novel Skeletons from Houttuynia cordata;Shao-Dan Chen et.al;《Organic Letters》;20120313;第14卷(第7期);第1772-1775页 * |
Shao-DanChenet.al.HouttuynoidsA-E Anti-Herpes Simplex Virus Active Flavonoids with Novel Skeletons from Houttuynia cordata.《Organic Letters》.2012 |
姜黄素联合木黄酮对人胰腺癌细胞株BXPC-3的作用;段红 等;《实用肿瘤杂志》;20041231;第19卷(第2期);第127-129页 * |
段红 等.姜黄素联合木黄酮对人胰腺癌细胞株BXPC-3的作用.《实用肿瘤杂志》.2004,第19卷(第2期),第127-129页. |
Also Published As
Publication number | Publication date |
---|---|
CN102872093A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102872093B (zh) | Houttuynoid E在治疗胰腺癌药物中的应用 | |
CN102861059B (zh) | Houttuynoid D在制备治疗胰腺癌药物中的应用 | |
CN102872122B (zh) | Houttuynoid B在制备治疗胰腺癌药物中的应用 | |
CN102872108B (zh) | Houttuynoid A在治疗胆管癌药物中的应用 | |
CN102861070B (zh) | Houttuynoid E在治疗舌癌药物中的应用 | |
CN102861050A (zh) | Houttuynoid A在治疗胰腺癌药物中的应用 | |
CN102872111B (zh) | Houttuynoid C在治疗胰腺癌药物中的应用 | |
CN102861058B (zh) | Houttuynoid D在治疗胆管癌药物中的应用 | |
CN102872144B (zh) | Houttuynoid D在制备治疗膀胱癌药物中的应用 | |
CN102861077B (zh) | Houttuynoid D在制备治疗宫颈癌药物中的应用 | |
CN102861096B (zh) | Houttuynoid E在制备治疗宫颈癌药物中的应用 | |
CN102872137B (zh) | Houttuynoid B在制备治疗宫颈癌药物中的应用 | |
CN102872070B (zh) | Houttuynoid C在治疗前列腺癌药物中的应用 | |
CN102872076B (zh) | Houttuynoid A在治疗舌癌药物中的应用 | |
CN102872139B (zh) | Houttuynoid C在治疗舌癌药物中的应用 | |
CN102872135B (zh) | Houttuynoid D在治疗肾癌药物中的应用 | |
CN102861064B (zh) | Houttuynoid E在制备治疗喉癌的药物中的应用 | |
CN102872148B (zh) | Houttuynoid D在治疗舌癌药物中的应用 | |
CN102861069B (zh) | Houttuynoid B在治疗喉癌药物中的应用 | |
CN102872112B (zh) | Houttuynoid A在制备治疗膀胱癌药物中的应用 | |
CN102872134B (zh) | Houttuynoid D在治疗喉癌药物中的应用 | |
CN102872072B (zh) | Houttuynoid B在治疗肾癌药物中的应用 | |
CN102872142B (zh) | Houttuynoid D在制备治疗卵巢癌药物中的应用 | |
CN102872125B (zh) | Houttuynoid C在治疗宫颈癌药物中的应用 | |
CN102872095B (zh) | Houttuynoid E在治疗回盲肠癌药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU XIN NEOLITHIC BASALT FIBER CO., LTD. Free format text: FORMER OWNER: WU JUNHUA Effective date: 20131209 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210009 NANJING, JIANGSU PROVINCE TO: 213351 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131209 Address after: 213351 Jiangsu city of Changzhou province Liyang Liyang Town of Wuhu Shanghai Road No. 168 Patentee after: Jiangsu Neolith Basalt Fiber Co., Ltd. Address before: 210009 No. 22, Hankou Road, Gulou District, Jiangsu, Nanjing Patentee before: Wu Junhua |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130828 Termination date: 20151027 |
|
EXPY | Termination of patent right or utility model |